Mississippi State University

Scholars Junction
College of Veterinary Medicine Publications and
Scholarship

College of Veterinary Medicine

9-6-2012

Rag1-/- mutant zebrafish demonstrate specific protection
following bacterial re-exposure.
Claudia Hohn
Lora Petrie-Hanson

Follow this and additional works at: https://scholarsjunction.msstate.edu/cvm-publications

Recommended Citation
Hohn, Claudia and Petrie-Hanson, Lora, "Rag1-/- mutant zebrafish demonstrate specific protection
following bacterial re-exposure." (2012). College of Veterinary Medicine Publications and Scholarship. 15.
https://scholarsjunction.msstate.edu/cvm-publications/15

This Article is brought to you for free and open access by the College of Veterinary Medicine at Scholars Junction.
It has been accepted for inclusion in College of Veterinary Medicine Publications and Scholarship by an authorized
administrator of Scholars Junction. For more information, please contact scholcomm@msstate.libanswers.com.

Rag12/2 Mutant Zebrafish Demonstrate Specific
Protection following Bacterial Re-Exposure
Claudia Hohn, Lora Petrie-Hanson*
Department of Basic Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Starkville, Mississippi, United States of America

Abstract
Background: Recombination activation gene 1 deficient (rag12/2) mutant zebrafish have a reduced lymphocyte-like cell
population that lacks functional B and T lymphocytes of the acquired immune system, but includes Natural Killer (NK)-like
cells and Non-specific cytotoxic cells (NCC) of the innate immune system. The innate immune system is thought to lack the
adaptive characteristics of an acquired immune system that provide enhanced protection to a second exposure of the same
pathogen. It has been shown that NK cells have the ability to mediate adaptive immunity to chemical haptens and
cytomegalovirus in murine models. In this study we evaluated the ability of rag12/2 mutant zebrafish to mount a protective
response to the facultative intracellular fish bacterium Edwardsiella ictaluri.
Methodology/Principal Findings: Following secondary challenge with a lethal dose of homologous bacteria 4 and 8 weeks
after a primary vaccination, rag12/2 mutant zebrafish demonstrated protective immunity. Heterologous bacterial exposures
did not provide protection. Adoptive leukocyte transfers from previously exposed mutants conferred protective immunity
to naı̈ve mutants when exposed to homologous bacteria.
Conclusions/Significance: Our findings show that a component of the innate immune system mounted a response that
provided significantly increased survival when rag12/2 mutant zebrafish were re-exposed to the same bacteria. Further,
adoptive cell transfers demonstrated that kidney interstitial leukocytes from previously exposed rag12/2 mutant zebrafish
transferred this protective immunity. This is the first report of any rag12/2 mutant vertebrate mounting a protective
secondary immune response to a bacterial pathogen, and demonstrates that a type of zebrafish innate immune cell can
mediate adaptive immunity in the absence of T and B cells.
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Historically, immunological dogma described the innate
immune response as acting naı̈vely to each encounter with a
pathogen depending on the recognition of conserved molecular
patterns and exhibiting only weak specificity. T and B cells
mediate protective secondary immune responses of the acquired
immune system, and immune-deficiencies develop in their
absence. However, evidence of adaptive responses of cells of the
innate immune system of mice to haptens and cytomegalovirus
have been demonstrated [7,8]. Natural Killer cells, an innate
lymphocyte population, can mount antigen-specific immunological memory [9,10,11,12,13]. Innate immune system memory may
be present in, and a more critical component of, lower vertebrate
immunity.
We used zebrafish (Danio rerio) to investigate an adaptive
component of innate immunity because specific mutants are
available and zebrafish are recognized as infectious disease models
[14,15,16]. Numerous regions of synteny between the zebrafish
and human genomes have been identified [17] allowing immunological findings in zebrafish to be translated to higher
vertebrates. Rag12/2 mutant zebrafish created by a reverse
genetic approach have been shown to lack VDJ recombination
[18]. After establishing a breeding colony, we further character-

Introduction
The immune system of fish provides important information
about conserved processes in the mammalian immune system.
Studies of antibody production in fish have revealed much about
the phylogeny of acquired immunity and immunoglobulins and
this has led to a better understanding of the overall functionality of
the immune system in all vertebrates (reviewed in [1,2]). Fish are
an excellent model for studying innate immunity since their innate
immune components are homologous to those of mammals. Their
acquired immunity differs from more advanced vertebrates in the
length of time needed to initiate a specific immune response
because of their poikilothermic nature [3]. Furthermore, other
than the mouse model, the rag12/2 mutant zebrafish is the only
animal model available for investigating T and B cell deficient
immunological responses. Interestingly, fish are not immunologically mature when they hatch. Acquired immunity, utilizing fully
functional T and B cells, does not develop until 3 to 6 weeks posthatch, depending on the species. In previous work channel catfish
(Ictalurus punctatus) larvae that had minimally organized lymphoid
tissue produced a protective secondary response to a bacterial
pathogen [4,5,6]. This suggested that in fish, there is an adaptive
component to innate immunity.
PLOS ONE | www.plosone.org
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ized the rag12/2 mutant zebrafish to confirm lack of T cell
receptor (TCR) and immunoglobulin (Ig) transcript expression
[19]. Therefore these fish do not have mature T and B cells and
thus are a unique model for characterizing innate immune system
memory in fish.
In this study, rag12/2 mutant zebrafish were given a primary
(vaccination) exposure to a low dose of a bacterial pathogen, or a
sham exposure. To determine protection, or how well the
vaccination worked, a secondary high dose exposure was delivered
at either four weeks (Trial 1) or eight weeks (Trial 2) after the
primary. The pathogens used were members of the Enterobacteriaceae family: Edwardsiella ictaluri, Yersinia ruckeri and E. tarda.
Edwardsiella ictaluri causes Enteric Septicemia of Catfish and a
comparable disease in zebrafish [14]. Edwardsiella ictaluri RE-33 is
an attenuated live vaccine (AQUAVAC-ESCH Intervet, Inc.) [20]
that was used for the vaccination (primary) exposure of E. ictaluri.
Yersinia ruckeri causes Yersiniosis or Enteric Red Mouth Disease
(ERM) primarily in salmonids [21]. Infection trials in our lab
demonstrated susceptibility of zebrafish to Y. ruckeri following
intramuscular (IM) injection. Edwardsiella tarda produces localized
and systemic infections in a wide variety of vertebrates and has
been shown to establish infections in zebrafish [22]. The aim of
this study was to utilize T and B cell deficient rag12/2 mutant
zebrafish to investigate adaptive protection of the innate immune
system in response to repeated bacterial exposure.

Preparation of Bacterial Cultures
Edwardsiella ictaluri, Yersinia ruckeri and Edwardsiella tarda were case
isolates from fish submitted to the Fish Diagnostic Lab at CVMMSU. Culture identifications were confirmed by biochemical
analysis using the bioMerieux api20E strip (BioMerieux, 69280
Marcy l’Etoile, France). Aliquots (0.5 ml) were stored in 20%
glycerol at 280uC until needed for trials, at which time one aliquot
was thawed and added into Brain Heart Infusion broth and
incubated in a shaker incubator at 30uC overnight. Logarithmic
phase cultures were obtained by dilution of the overnight culture
1:10 and grown until the optical density was 0.4 at 540 nm which
corresponds to 108 colony forming units (CFU) per ml. Culture
purities were assessed and bacterial concentrations determined by
plating serial dilutions on 5% sheep blood plates.

Lethal Dose (LD.80) Determination
In separate trials, rag12/2 mutant zebrafish were injected with
E. ictaluri, Y. ruckeri, or E. tarda (106, 105, 104, 103, 102, or 101
CFU/fish) to determine LD.80 dosage for the secondary exposure,
referred to as the protection exposure (to determine if the
vaccination exposure provided protection). Injections of rag12/2
mutant zebrafish were performed using four replicate tanks per
treatment with 15 fish per replicate. Additionally 15 control fish
per strain were sham injected. Mortalities were recorded for 18
days post injection (dpi), and LD.80 dosages were determined
from these data (Figure S1).

Materials and Methods
Bacterial Injections and Experimental Observations

Animal Care

Primary and secondary injections were carried out as described
in Table 1. In all trials, adult (6–9 month old) rag12/2 mutant
zebrafish were anesthetized in 110 mg/L buffered tricaine
methane sulfonate (MS222). Each fish was IM injected on the
lateral line above the anal fin using an insulin syringe. All primary
vaccinations were 104 CFU/fish RE33, a commercial, live,
attenuated Edwardsiella ictaluri vaccine strain (AQUAVAC-ESCH
Intervet, Inc.) [20]. The secondary exposure was delivered at
either 1 month (Trial 1) or 2 months (Trial 2) post-vaccination and
consisted of one of the following bacteria: 104 CFU/fish
Edwardsiella ictaluri, 106 CFU/fish Yersinia ruckeri, or 102 CFU/fish
Edwardsiella tarda (Table 1). These dosages have been established in
our laboratory as the LD.80 dosage for each bacteria. This
secondary injection is referred to as protection exposure (to
determine if the vaccination exposure provided protection). All
injections were delivered in a total volume of 10 ml phosphate
buffered saline (PBS). Sham injected fish received 10 ml PBS. After
recovery from anesthesia, fish were moved to tanks in a flow–

2/2

Rag1
mutant zebrafish were housed in the Mississippi State
University College of Veterinary Medicine (MSU-CVM) specific
pathogen free (SPF) fish hatchery. Fish were propagated according
to modified standard protocols posted at: http://www.cvm.
msstate.edu/zebrafish/index.html. The Institutional Animal Care
and Use Committee at Mississippi State University approved all
experimental animal protocols.

Genotype Control
All rag12/2 mutant zebrafish used for this study were bred at
the CVM-SPF fish hatchery. We established a homozygous
rag12/2 mutant zebrafish breeding colony, and all of our
experimental fish are progeny from this colony. For an additional
genotype control we sub-sampled zebrafish (10 fish per spawn)
shortly before the experiment and the genotype, rag12/2, was
confirmed using previously established PCR protocols [19].

Table 1. Summary of the trials performed to determine the basis of protection following bacterial re-exposure in rag12/2 mutant
zebrafish.

Trial

Treatment; Objective; # of experiments; tanks/treatment; fish/tank

Secondary

E. ictaluri RE33 10

4

4 week interval; Determine if protection occurs; 3 exps; 3 tanks/trt; 24 fish/tank

E. ictaluri 104

2

E. ictaluri RE33 10

4

8 week interval; Rule out temporarily heightened primary effects; 2 exps; 8 tanks/trt;
10 fish/tank

E. ictaluri 104

3

E. ictaluri RE33 104

4 week interval with antibiotic administered; Rule out persistent pathogen presence;
2 exps; 8 tanks/trt; 10 fish/tank

E. ictaluri 104

4

E. ictaluri RE33 104

4 week interval with homologous or heterologous secondary; Determine specificity;
1 exp; 4 tanks/trt; 15 fish/tank

E. ictaluri 104 Y. ruckeri 106
E. tarda 102

5

E. ictaluri RE33 104

4 week interval with adoptive cell transfers; determine if protection provided by
a leukocyte population; 1 exp; 7 tanks/trt; 15 fish/tank

E. ictaluri 104

1

Primary

doi:10.1371/journal.pone.0044451.t001

PLOS ONE | www.plosone.org

2

September 2012 | Volume 7 | Issue 9 | e44451

Protection of rag1 Mutant Zebrafish

Figure 1. Comparison of survival by day (left panel) and cumulative mortality (right panel) between naı̈ve and vaccinated rag12/2
mutant zebrafish in Trial 1. Asterisk indicates a significantly lower mortality rate in vaccinated rag12/2 mutant zebrafish when compared to naı̈ve
rag12/2 mutant zebrafish. Fish were vaccinated with RE33H an attenuated strain of E. ictaluri and 4 weeks later challenged by a secondary injection of
virulent E. ictaluri. DPI = days post secondary exposure. Error bars indicate standard error of the mean, SEM, between tanks (n = 9).
doi:10.1371/journal.pone.0044451.g001

the experiments to ensure good water quality and to minimize
the risk of bacterial accumulation. In a previous study we
showed that immersion exposed zebrafish did not establish an
infection when exposed to 105 CFU/mL of tank water for 2
hours [14]. Therefore, the likelihood of bacterial transmission
through the water is very low.
In Trial 1, we compared the susceptibility and adaptive
protection of rag12/2 mutant zebrafish when challenged with
E. ictaluri. For the primary vaccination exposure, rag12/2 mutant
zebrafish were injected with 104 CFU/fish of the attenuated strain
of RE33 E. ictaluri, or PBS only (controls). For the secondary or
protection exposure, rag12/2 mutant zebrafish were injected with
104 CFU of E. ictaluri/fish 4 weeks after the vaccination exposure.
Naı̈ve rag12/2 mutant zebrafish were also injected with 104
CFU/fish E. ictaluri. Negative controls included mutants injected
with PBS only at the primary and secondary exposure, and
mutants that were not injected at all.
It is known that for a short time after the primary exposure the
innate immune response is heightened, and if that heightened
response is present when the secondary exposure is given,
protection could be non-specific. To rule out this effect in Trial
2, we performed the same experiment as in Trial 1, except we
increased the time between the vaccination and protection

through water system and maintained at 27uC61u. All fish were
held under the same conditions during all experiments and were
observed 3 times a day for clinical signs of disease. Moribund fish
were euthanatized in 340 mg/L MS222, and sampled for bacterial
re-isolation. Mortalities were recorded for 10 days post-protection
exposure.

Re-isolation of Bacteria
After protection exposures, deaths were recorded, and a 10 ml
loop of each dead fish’s brain was plated on 5% sheep blood
plates. After 24 to 48 h at 28uC, bacterial identifications were
confirmed by biochemical analysis using the bioMerieux api20E
strip (BioMerieux, 69280 Marcy l’Etoile, France).

Overview of Exposure Trials
Five different trials were designed to progressively determine
the basis of adaptive immunity in rag12/2 mutant zebrafish
(Table 1). Lethal Dose trials determined the dose of bacteria per
fish required to kill 80% of a naı̈ve population in the secondary
exposure. Throughout Trials 1–4 we followed the general set-up
as outlined in Table 1. For negative controls, fish were injected
with sterile PBS (sham). For each trial, a tank of non-injected
sentinel fish was also included. Since infected fish can shed
bacteria, all tanks were on flow-through (0.5 L/min) throughout
PLOS ONE | www.plosone.org
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Figure 2. Comparison of survival by day (left panel) and cumulative mortality (right panel) between naı̈ve and vaccinated rag12/2
mutant zebrafish in Trial 2. Asterisk indicates a significantly lower mortality rate in vaccinated rag12/2 mutant zebrafish when compared to naı̈ve
rag12/2 mutant zebrafish. Fish were vaccinated with RE33H an attenuated strain of E. ictaluri and 8 weeks later challenged by a secondary injection of
virulent E. ictaluri. DPI = days post secondary exposure. Error bars indicate standard error of the mean, SEM, between tanks (n = 16).
doi:10.1371/journal.pone.0044451.g002

functions, fish kidney tissue is functionally equivalent to vertebrate
bone marrow and is a primary lymphoid tissue. It consists of renal
corpuscles and collecting tubules with an interstitial matrix of
hematopoietic tissue that includes hematopoietic stem cells,
macrophages, neutrophils, NCC and NK cells in rag12/2 mutant
zebrafish [19]. To validate adoptive cell transfer experiments in
rag12/2 mutant zebrafish, we performed preliminary transfer
experiments using carboxyfluorescein diacetate succinimidyl ester
(CSFE) labeled cells. The mutant zebrafish population used in this
trial was in-bred for 5 generations to minimize recognition of
transfused cells by the recipient.

exposures to eight weeks. Set-up and procedures performed were
the same as described in Trial 1.
Trial 3 was performed to confirm that there was not a persistent
low-level infection that was continually stimulating the innate
immune system. In previous trials, sub-samples of vaccinated fish
were cultured for bacteria and found to be negative, but a low level
of infection may escape detection. Therefore, we administered
oxolinic acid, an antibiotic used as a feed additive in fish. The fish
received feed supplemented with oxolinic acid (7 mg/gm) daily for
7 days (fed to satiation) starting at 10 days post the primary
vaccinations.
In Trial 4, we determined the specificity of protection by
performing heterologous (different bacteria species in primary and
secondary exposures) bacteria challenges. Rag12/2 mutant
zebrafish were vaccinated with 104 CFU E. ictaluri RE33/fish or
sham injected (Table 1). Four weeks later these fish were injected
with 104 CFU E. ictaluri/fish, 106 CFU Y. ruckeri/fish or 102 CFU
E. tarda/fish; these were dosages that resulted in greater than 80%
mortality of naı̈ve fish in Lethal Dose trials. Post-exposure
procedures were the same as described in the other trials.
Trial 5 was performed to determine if we could transfer
protection by transferring innate immune cells from vaccinated
rag12/2 mutant zebrafish into naı̈ve rag12/2 mutant zebrafish
before they were exposed to bacteria. In addition to blood filtering
PLOS ONE | www.plosone.org

Preparation and Recovery of Carboxyfluorescein
Diacetate Succinimidyl Ester (CFSE) Stained Donor Cell
Suspensions
Kidney tissue was dissected from 10 rag12/2 mutant zebrafish
and prepared following established procedures in our lab [23].
The cell suspension was diluted to 106 cells/ml in PBS. The CFSE
probe was prepared according to manufacturer’s directions
(CellTraceTM CFSE Cell Proliferation Kit (C34554) Molecular
ProbesTM). Five mM of CFSE probe per ml of cell suspension was
added, and then incubated for 15 min at 30uC. The cell
suspension was centrifuged at 400 g for 5 min, and the cell pellet
re-suspended in tissue culture medium to obtain 108 cells/ml.
4
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Figure 3. Comparison of survival by day (left panel) and cumulative mortality (right panel) between naı̈ve and vaccinated rag12/2
mutant zebrafish fed antibiotic feed in Trial 3. Asterisk indicates a significantly lower mortality rate in vaccinated rag12/2 mutant zebrafish
when compared to naı̈ve rag12/2 mutant zebrafish. Fish were vaccinated with RE33H an attenuated strain of E. ictaluri and 4 weeks later challenged
by a secondary injection of virulent E. ictaluri. Ten days after the vaccination, fish received feed supplemented with oxolinic acid for 7 days. DPI = days
post secondary exposure. Error bars indicate standard error of the mean, SEM, between tanks (n = 16).
doi:10.1371/journal.pone.0044451.g003

CFSE stained cells (10 ml) were injected intraperitoneally (IP) into
recipient rag12/2 mutant zebrafish delivering 106 cells/fish.
Control fish were injected with 10 ml of PBS. Fish were held in
flow through tanks until sampled, and recipient kidneys were
sampled as previously described. Flow cytometric analyses of
adopted cells were performed on 3 replicates of adopted stained
cells and 3 control replicates at 1, 24, and 48 hours, and 3, 4, 7, 10,
18 days post-injection.
In Trial 5, we performed adoptive transfers of renal interstitial
cells from vaccinated and naı̈ve rag12/2 mutant zebrafish (Figure
S2). All adoptive transfers were carried out by infusing all the
interstitial kidney leukocytes from the kidney of a single donor into
a naı̈ve recipient. Primary vaccinations were carried out as
described in Trial 1 to provide donor rag12/2 mutant zebrafish.
Four weeks post-vaccination, kidneys of vaccinated rag12/2
mutant zebrafish were removed, dissociated and cells were rinsed.
Vaccinated donor leukocytes were IP injected into naı̈ve recipient
rag12/2 mutant zebrafish (Group 1). Cells from naı̈ve rag12/2
mutant zebrafish were transferred into Group 2, and naı̈ve control
rag12/2 mutant zebrafish did not receive cells (Group 3).
Appropriate control groups included a transfused cell control
group to rule out the effects of enhanced anti-bacterial activity
resulting from non-specific cellular activation due to MHC or
PLOS ONE | www.plosone.org

other transplantation antigen differences. Twenty-four hours later,
fish received a secondary homologous exposure and were
designated Groups 1a, 2a and 3. Control groups received PBS
and were designated Groups 1b and 2b (Figure S2).

Statistical Methods
Cumulative mortality was calculated in trials 1, 2, 3 and 5.
Relative percent survival (RPS) [(1- mean mortality of vaccinated/
mean mortality of sham vaccinated) x 100] was calculated for Trial
4, homologous and heterologous exposures, because RPS is a
more robust analysis for protection to determine specificity.
Treatment groups for each trial are described above. Number of
tanks per treatment and number of fish per tank are shown in
Table 1. Each tank was treated as a biological replicate. Mortality
data of treatments between groups were analyzed by one-way
analysis of variance (ANOVA) with post hoc Tukey HSD
correction for multiple comparisons with a level of significance
at p#0.05. Statistical analyses were performed using SPSS for
Windows 15.0 (SPSS Inc., Chicago, IL).
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Figure 4. Homologous and heterologous protection trial in Trial 4. Percent survival, A, and relative percent survival [(1– mean mortality of
vaccinated/mean mortality of sham vaccinated) 6 100] B, of E. ictaluri RE33H vaccinated rag12/2 mutant zebrafish after secondary challenge with
E. ictaluri, Y. ruckeri or E. tarda. Error bars indicate standard deviation between tanks (n = 4).
doi:10.1371/journal.pone.0044451.g004

protection with a cumulative mortality of 37.5% compared to
72.5% in naı̈ve rag12/2 mutant zebrafish (Figure 3). Edwardsiella
ictaluri isolated from moribund fish post the secondary exposure
were sensitive to oxolinic acid. These findings demonstrate that
protection in the rag12/2 mutant zebrafish was not due to
bacteria persisting within the fish.
In Trial 4, rag12/2 mutant zebrafish vaccinated with E. ictaluri
demonstrated significantly reduced mortality following secondary
E. ictaluri exposure, but were not protected against secondary
Y. ruckeri or E. tarda exposures (Figure 4). Thus, homologous
exposures provided specific adaptive protection whereas heterologous exposures did not.
To validate adoptive cell transfer experiments in rag12/2
mutant zebrafish, we performed preliminary transfer experiments
using carboxyfluorescein diacetate succinimidyl ester (CSFE)
labeled cells. We modified standard procedures to perform
adoptive cell infusions, or transfusions, in zebrafish. We successfully isolated kidney leukocytes, CFSE stained these cells, and IP
injected them into recipient fish. After re-isolating stained cells
from recipient kidney tissue and performing flow cytometric
analyses on them, we compared their tissue distribution to naı̈ve

Results
In Trial 1, a significantly lower cumulative mortality of 28% was
seen in vaccinated rag12/2 mutant zebrafish, while naı̈ve rag12/2
mutant zebrafish suffered a cumulative mortality of 75% (Figure 1).
No losses occurred in the control fish and randomly selected
rag12/2 mutant zebrafish cultured negative for E. ictaluri. These
findings demonstrate that in vaccinated rag12/2 mutant zebrafish,
a form of adaptive protection occurred.
In Trial 2, we saw similar results as in Trial 1. Cumulative
mortality in naı̈ve rag12/2 mutant zebrafish was 52.5%. As
expected, mortality of vaccinated rag12/2 mutant zebrafish
decreased significantly to 17.5% (Figure 2). These results
demonstrate that protection in rag12/2 mutant zebrafish is not
due to a temporarily heightened post-primary response. The
results also demonstrate that a component of innate immunity in
rag12/2 mutant zebrafish is capable of mediating adaptive
protective immunity following vaccination.
In Trial 3, randomly sampled fish cultured negative for E. ictaluri
before evaluating protection. This trial resulted in a similar
significant cumulative mortality as in Trial 1 and 2. Vaccinated
rag12/2 mutant zebrafish demonstrated significantly greater
PLOS ONE | www.plosone.org
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Figure 5. Flow cytometry data of CFSE stained leukocytes re-isolated from recipient rag12/2 mutant kidneys. A. Scatter plot of kidney
leukocytes demonstrating the gating of cell populations (gate 1 is phagocytes, gate 2 is lymphocyte like cells). B. Histogram of positive control: CFSE
stained cells injected into the recipient. C. Histogram of negative control: cells isolated from a PBS injected fish. D. Histograms CSFE stained cell
counts from gate 1 (phagocytes) and gate 2 (lymphocyte like) from kidney tissue of recipient rag12/2 mutants at 24 h post infusion. E. Graph
indicating the CFSE stained cell counts in the kidney of transfused fish at 1 h, then 1, 2, 3, 4, 7 and 18 days post transfusion. Error bars indicate
standard deviation (n = 2).
doi:10.1371/journal.pone.0044451.g005

adopted cells. Our findings demonstrate that transfused donor cells
were stable for greater than 7 days in recipient fish (Figure 5).
In Trail 5, group 1a received vaccinated cells and the
cumulative mortality was significantly less (29.5%) when compared
to rag12/2 mutant zebrafish that received naı̈ve cells, or no cells at
all (Figure 6). Vaccinated kidney interstitial cells from rag12/2
mutant zebrafish mediated specific adaptive protection in naı̈ve
recipients. Significantly higher cumulative mortalities were seen in
exposed rag12/2 mutant zebrafish that received naı̈ve cells and
exposed rag12/2 mutant zebrafish that did not receive any cells,
78% and 58% respectively. Since these two treatments were not
significantly different from each other, an increased number of
naı̈ve cells alone did not provide protection.

PLOS ONE | www.plosone.org

Discussion
We have utilized T and B cell deficient rag12/2 mutant
zebrafish to investigate adaptive protection in response to bacterial
infections in the absence of an acquired immune system. These
mutant fish have increased numbers of neutrophils [19] and
increased expression of genes associated with innate defenses [24].
This is the likely explanation for the ability of lymphocyte deficient
zebrafish to resolve primary infection. More intriguing is our
finding of significant differences in mortality upon secondary
exposure, which demonstrates that rag12/2 mutant zebrafish are
able to develop and maintain protective immunity following a
primary vaccination exposure. Furthermore, specificity was
demonstrated when infection success was significantly reduced
after previous contact with the same pathogen (homologous
exposure), but not to a different pathogen (heterologous exposure).
The cells that mediated specific recognition and a protective
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Figure 6. Comparison of survival by day (left panel) and cumulative mortality (right panel) in Adoptive Immunity Trial 5. Asterisk
indicates that recipients of vaccinated transferred kidney interstitial cells (Group 1a) had significantly lower (p,0.05) mortality than recipients of naı̈ve
transferred cells (Group 2a), or naı̈ve fish injected with E. ictaluri (Group 3). DPI = days post injection of the secondary exposure. Error bars indicate
standard deviation between tanks (n = 7).
doi:10.1371/journal.pone.0044451.g006

adoptive transfer studies indicated NK cells were the specific
leukocyte involved. However, a specific receptor or mechanism
imparting this memory was not found [7]. Another investigation of
the involvement of NK cells in epidermal responses suggested that
NK cells do not mediate specific memory in a murine skin
transplant model, but will mediate acute skin allograft rejection
after IL-15 stimulation in the absence of any adaptive immune
cells [26].
Sun and Lanier utilized B6 mice and the mouse cytomegalovirus to investigate the role of NK cells in a viral infection [8].
Following initial infection, NK (Ly49H receptor+) cells proliferated 100x in the spleen and 1000x in the liver. After a contraction
phase, these NK cells resided in various tissues for several months.
Following secondary exposure, or viral reactivation, memory NK
cells were found to rapidly degranulate and produce cytokines,
resulting in protection. Adoptive transfer of these NK cells also
conveyed protective immunity. For the first time, immune
responses of NK cells were found to undergo all four phases:
expansion, contraction, memory maintenance and recall response,
previously attributed only to cells of the adaptive immune system.
Unlike T and B cells that express one antigen-specific type of
receptor after encountering a pathogen, NK cells have been found
to express an array of receptors with distinct specificity [8,27].
Natural Killer cells may preserve a more general adaptive

response upon secondary exposure performed these same functions when transferred into naı̈ve rag12/2 mutant zebrafish. Our
finding of adaptive protection mediated by the innate immune
system of zebrafish parallels similar findings in lymphocyte
deficient mice. Furthermore, our findings are unique because
they are the first demonstration of a T and B cell deficient rag12/2
mutant vertebrate to mount an adaptive protective response to
bacteria.
Natural Killer cells are the most likely innate immune cell
mediating protective immunity in rag12/2 mutant zebrafish.
Natural Killer cell genes that encode pathogen recognition
receptors do not undergo gene rearrangement [25]. Research on
the functions of NK cells in mice have demonstrated adaptive,
acquired immune responses [7]. A hapten-based hypersensitivity
study was the first to suggest NK cells had the capacity of memory
in Rag-2 deficient Severe Combined Immunodeficient (SCID)
mice [7]. Severe Combined Immunodeficient mice possess NK
cells but are devoid of T and B lymphocytes. These mice
demonstrated substantial contact hypersensitivity responses to
haptens that persisted for 28 days and was elicited only by haptens
to which mice were previously sensitized [7]. No contact
hypersensitivity was induced in another type of mouse lacking
NK cells (and T and B cells), suggesting that NK cells were
mediating a true adaptive secondary response [7]. Further,

PLOS ONE | www.plosone.org
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protection similar to what is observed in memory T cells, where
interleukin-12 produced by dendritic cells triggers interferongamma production in the absence of cognate antigen [28].
Receptors on mammalian NK cells that could provide memory
function and cross-reactivity have been discussed [25,28,29].
Human NK cells can be activated by direct contact with
Mycobacterium via the NKp44 natural cytotoxicity receptor [30].
This activation occurs in the absence of monocytes/macrophages
and IL-12. In bony fish the NK cell receptor functional orthologs
are novel immune-type receptors (NITRs) [31,32]. Like NK cell
receptors in mammals, NITRs can function to either inhibit or
activate NK cell cytotoxicity and/or cytokine release [32]. A group
of secreted NITRs have been suggested to dimerize with
membrane-bound NITRs or other membrane-bound molecules
involved in immune recognition, or they may bind to foreign body
surfaces [33]. The structure of an activating NITR on a cytotoxic
NK-like cell line has been characterized as resembling antigen
binding receptors that demonstrate specific recognition, and these
receptors might undergo lineage-restricted somatic variation
conveying specific protection upon re-encounter with the same
pathogen [31]. Based on our studies that have demonstrated
specific secondary immune responses of T and B cell deficient
rag12/2 mutant zebrafish, and evidence that fish NK cells
demonstrate the capacity of specific recognition of diverse
molecules [31], we believe that a population of zebrafish NK
cells mediate memory, and that zebrafish NK cells have a
mechanism for enhanced discrimination of a bacterial target
following primary exposure.
In addition, other receptors have been shown to be important in
recognizing intracellular pathogens. Two are of particular interest,
the tripartite motif (TRIM) proteins and NOD-like receptor (NLR)
molecules. Both have been shown to be present and very diverse in
zebrafish. The zebrafish genome encodes 240 TRIMs [34]. Many
of them have the B30.2 domain and an important ligand binding
domain [35]. This region displays a high level of positive selection
for diversification in zebrafish [35]. The zebrafish genome also
encodes 5 NLR A family members, 6 NLR B family members and
several hundred NLR C family members [36]. Like the diverse
TRIMs, the NLR Cs contain the B30.2 domain with high diversity
[36]. Involvement of cytosolic receptors in the host response to
E. ictaluri is suggested by the demonstration of up regulation of the
NLR designated NOT1 in infected channel catfish [37]. Because
these receptors are cytosolic, any protection imparted would likely
be phagocyte mediated.

Memory is a term that has been only used in acquired immunity
therefore we referred to innate immune system memory as
adaptive protection throughout this text. Heterologous bacterial
challenges demonstrated that the immune system of rag12/2
mutant zebrafish exhibits adaptive characteristics and specificity.
Adoptive cell transfers demonstrated that kidney interstitial cells
mediated the specific adaptive protection. Our research demonstrates that innate immune cells are capable of mediating specific
adaptive protection and that vaccination in rag12/2 mutant
zebrafish results in significantly increased survival if the fish are reexposed to the same pathogen.
Even if it is ultimately revealed that adaptive protection is more
important in fish than mammals, understanding this immune
response in fish will help to understand its phylogenetic
development. The broader spectrum provided by memory of
innate immunity would influence an individual’s ability to respond
to classes of pathogens and direct the type of acquired response
induced. Innate memory could be partially responsible for
variation and alterations of immune function in immuneassociated diseases and could be directed to help with deficiencies
in acquired immune components.

Supporting Information
Lethal Dose (LD) trials for Edwardsiella
ictaluri, Edwardsiella tarda and Yersinia ruckeri in
rag12/2 mutant and wild-type zebrafish. Four replicate
tanks per treatment with 15 fish per replicate were injected with
indicated dosages of bacteria and 15 control fish per strain were
sham injected with PBS. Mortalities were recorded for 18 days
post injection (DPI). No mortalities were observed in the control
fish.
(TIF)

Figure S1

Figure S2 The experimental design of Trial 5, Adoptive
cell transfers in rag12/2 mutant zebrafish.
(TIF)
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